Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2023-09-26 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Interim results
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive 'Half-year Report' for EKF Diagnostics Holdings plc for the period ended 30 June 2023. It contains detailed financial statements, operational highlights, divisional revenue breakdowns, and management commentary. It is not a mere announcement of a report, but the report itself, containing substantive financial data and analysis. Therefore, it is classified as an Interim/Quarterly Report. H1 2023
2023-09-26 English
Notice of Results & Investor Presentation
Regulatory Filings Classification · 1% confidence The document is a short announcement (3688 characters) issued via RNS (RNS Number: 3552M) by EKF Diagnostics Holdings plc. The title explicitly states 'Notice of Interim Results & Investor Presentation'. It confirms the date the interim results (H1 2023) will be announced and details an accompanying investor presentation event. Because this document is an announcement about the upcoming release of results and a presentation, rather than the full results (IR) or the presentation slides themselves (IP), it fits the definition of a Report Publication Announcement (RPA). It is not a general regulatory filing (RNS) because RPA is more specific for announcing the publication of other reports.
2023-09-14 English
Trading Update
Earnings Release Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a 'Trading Update' with revised financial guidance for FY 2023, including revenue and adjusted EBITDA expectations. It also mentions the upcoming announcement of 'unaudited results for H1 2023'. This content—a brief update on performance and guidance revision, disseminated via the RNS system (London Stock Exchange's news service)—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides key financial highlights and guidance changes rather than the full, detailed financial statements (which would be an IR or 10-K), 'ER' is the most appropriate classification. It is not a full transcript (CT), a proxy statement (PSI), or a formal annual report (10-K). Given the RNS source and the nature of the update, it fits the 'Earnings Release' definition best, although 'RNS' is a close secondary option if ER were not available or if the content was purely administrative. FY 2023
2023-09-12 English
Appointment of CFO
Board/Management Information Classification · 1% confidence The document is a formal announcement released via RNS (the news service of the London Stock Exchange), indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the FCA. The core content announces the 'Appointment of CFO' (Chief Financial Officer), Stephen Young. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-09-12 English
Trading Update
Regulatory Filings Classification · 1% confidence The document is an unaudited trading update for the six months ended 30 June 2023 (H1 2023). It provides key financial highlights (revenues, cash position) and operational updates for a specific interim period, but it is not the full, comprehensive report itself (which would be an 'IR'). It is an initial announcement of period results, focusing on key figures and management commentary, which aligns perfectly with the definition of an Earnings Release (ER). The document explicitly states it is a 'Trading Update' and mentions the upcoming announcement of 'unaudited results for H1 2023' on a future date (September 26, 2023), confirming this document serves as the preliminary earnings announcement.
2023-07-26 English
Directorate Change
Board/Management Information Classification · 1% confidence The document is an official announcement filed under 'RNS Number' and contains the header 'This announcement contains inside information for the purposes of UK Market Abuse Regulation.' The core content details the standing down of the Chief Financial Officer (CFO) and the ongoing search for a replacement. This directly relates to changes in senior management personnel. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (4219 chars) is not indicative of a full report, but the content is specific enough to avoid the general 'RNS' fallback.
2023-06-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.